Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harry

Showing results (21-30 of 98) with videos related to

Pageof 10
Sort By:
Obstetrics and Gynecology|August 2, 2007
Isolated clear cell adenocarcinoma in scar endometriosis mimicking an incisional herniaVanessa N Harry, Smruta Shanbhag, Matthew Lyall, et al.
European Journal of Cancer Care|August 28, 2009
The genetic causes of the sequential occurrence of multiple primary malignancies in a young woman--5 years onV N Harry, G P Cumming, G V Narayansingh, et al.
Current Pharmaceutical Design|November 11, 2008
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistanceAstrid A M van der Veldt, Gert Luurtsema, Mark Lubberink, et al.
EJNMMI Research|September 22, 2023
CYP3A4 inhibitors do not influence [<sup>68</sup>Ga]Ga-DOTA-TATE uptake in liver tissueYoussef Chahid, Faouzi Chahid, Ewoudt van de Garde, et al.
Chemotherapy|January 1, 1989
Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patientsH Trujillo, N Harry, A Arango, et al.
Bone|August 7, 2016
Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastasesRogier Lange, Rob Ter Heine, Russ Ff Knapp, et al.
Age and Ageing|March 5, 2003
The effects of improving hearing in dementiaN Harry Allen, Alistair Burns, Valerie Newton, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 19, 2015
Synthesis of [3-N-(11) C-methyl]temozolomide via in situ activation of 3-N-hydroxymethyl temozolomide and alkylation with [(11) C]methyl iodideJonas Eriksson, Rolph Van Kooij, Robert C Schuit, et al.
Nuclear Medicine Communications|February 4, 2015
Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approachRogier Lange, Rob ter Heine, Clemens Decristoforo, et al.
Cancers|March 10, 2022
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate CancerWietske I Luining, Matthijs C F Cysouw, Dennie Meijer, et al.
Pageof 10

Showing results (21-30 of 98) with videos related to

Sort By:
Pageof 10
Obstetrics and Gynecology|August 2, 2007
Isolated clear cell adenocarcinoma in scar endometriosis mimicking an incisional herniaVanessa N Harry, Smruta Shanbhag, Matthew Lyall, et al.
European Journal of Cancer Care|August 28, 2009
The genetic causes of the sequential occurrence of multiple primary malignancies in a young woman--5 years onV N Harry, G P Cumming, G V Narayansingh, et al.
Current Pharmaceutical Design|November 11, 2008
Individualized treatment planning in oncology: role of PET and radiolabelled anticancer drugs in predicting tumour resistanceAstrid A M van der Veldt, Gert Luurtsema, Mark Lubberink, et al.
EJNMMI Research|September 22, 2023
CYP3A4 inhibitors do not influence [<sup>68</sup>Ga]Ga-DOTA-TATE uptake in liver tissueYoussef Chahid, Faouzi Chahid, Ewoudt van de Garde, et al.
Chemotherapy|January 1, 1989
Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patientsH Trujillo, N Harry, A Arango, et al.
Bone|August 7, 2016
Pharmaceutical and clinical development of phosphonate-based radiopharmaceuticals for the targeted treatment of bone metastasesRogier Lange, Rob Ter Heine, Russ Ff Knapp, et al.
Age and Ageing|March 5, 2003
The effects of improving hearing in dementiaN Harry Allen, Alistair Burns, Valerie Newton, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 19, 2015
Synthesis of [3-N-(11) C-methyl]temozolomide via in situ activation of 3-N-hydroxymethyl temozolomide and alkylation with [(11) C]methyl iodideJonas Eriksson, Rolph Van Kooij, Robert C Schuit, et al.
Nuclear Medicine Communications|February 4, 2015
Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approachRogier Lange, Rob ter Heine, Clemens Decristoforo, et al.
Cancers|March 10, 2022
Targeting PSMA Revolutionizes the Role of Nuclear Medicine in Diagnosis and Treatment of Prostate CancerWietske I Luining, Matthijs C F Cysouw, Dennie Meijer, et al.
Pageof 10